As most breast cancers are found in older, postmenopausal women, a reasonable but not widely considered explanation is it that PgR assays in these women are compromised because their low endogenous levels of estradiol are insufficient to elevate PgR levels, even when ER is active. Here, PGR is linked to breast carcinoma.